Hematology NewsMyeloma: FDA Advisers Greenlight Early CAR-TMarch 18, 2024Multiple MyelomaCellular Therapy
Oncology PracticeRUBY: ‘A Huge Win’ for Patients With Advanced or Recurrent Endometrial CancerMarch 18, 2024Gynecologic CancerGynecologyPatient & Survivor Care
Oncology PracticeCell-Free DNA Blood Test Has High Accuracy for Detecting Colorectal CancerMarch 18, 2024GI OncologyGastroenterologyOncologyPreventive CareGastrointestinal Cancer
Oncology PracticeCombining Targeted Drugs and Radiation in Breast Cancer: What’s Safe?March 18, 2024Breast CancerPatient & Survivor CareMixed TopicsMetastatic Breast Cancer
Oncology PracticeFDA Approves New Esophageal Cancer DrugMarch 18, 2024Gastrointestinal CancerGastroenterology
Hematology NewsFDA Approves First CAR T-Cell Therapy for rrCLL, rrSLLMarch 15, 2024CLLCellular Therapy
Oncology PracticeConsider These Factors in an Academic Radiation Oncology PositionMarch 14, 2024Practice ManagementBreast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanomaMetastatic Breast CancerNeuro-oncologyNonmelanoma Skin CancerRenal Cell CarcinomaSarcoma & GISTAggressive LymphomasALLAMLB Cell LymphomaBusiness of MedicineCLLCMLDLBCLHodgkin LymphomaIndolent LymphomaMantle Cell LymphomaMixed TopicsMultiple MyelomaNon-Hodgkin LymphomaT Cell Lymphomas
Oncology PracticeMedicare Doc Pay Cut Eased, but When Will Serious Revisions Come?March 14, 2024Business of MedicinePractice Management
Meta-analysis Identifies Unique Risk Factors of Triple-Negative Breast CancerMarch 14, 2024Breast Cancer
Real-World Study Supports Everolimus + Exemestane as HR+/HER2− BC TreatmentMarch 14, 2024Breast Cancer
Axillary Lymph Node Dissection Can Be Safely Skipped in Breast Cancer Patients Undergoing MastectomyMarch 14, 2024Breast Cancer
Breast-Conserving Surgery Does Not Increase Locoregional Recurrence in TNBCMarch 14, 2024Breast Cancer